Insights On Facility Design
-
Proposed vs. Actual Cleanroom Construction Costs And Delivery Timelines
8/24/2018
When it comes to facilities or cleanroom infrastructures in the biopharmaceutical or cell/gene therapy industry, not only does management rely on what has been promised, but also the patients.
-
The Evolution Of Biopharmaceutical Facility Designs
8/22/2018
In the lifecycle of pharmaceutical and biopharmaceutical commercial manufacturing, the one constant has been change. With the advent of modern therapeutics, large scale commercial manufacturing became common place.
-
Can A Shared Biomanufacturing Facility Be The Answer To The Demand Forecasting Dilemma?
8/13/2018
Using a shared biomanufacturing facility, a biomanufacturer can minimize its investment while mitigating the risks of demand uncertainty and maximizing time to market.
-
The Top Trends Influencing Automation In The Life Science Industry
7/6/2018
Trevor Marshall of Zenith Technologies discusses the impact that multi-product manufacturing facilities, single-use technologies, continuous manufacturing and industry 4.0 will have on automation.
-
Build Efficiency Through Continuous Characterization
2/9/2018
Bioprocessing development is a long and costly process. Building in continuous characterization and connected bioprocessing cuts timelines and increases the available information through real-time analytics.
-
Are You Ready For The Future Of Biomanufacturing?
1/19/2018
As novel medicines become a larger part of the industry's portfolio, it is critical you secure a supply chain and manufacturing processes that produce drugs in a reliable, cost-effective way.
-
A Molecule’s Journey – Break Down Roadblocks To Commercial Success
1/4/2018
A guide for today’s biopharma executives seeking to navigate through the important considerations necessary to successfully build their own cGMP biomanufacturing facility.
-
Fast-Tracking A QbD Approach
12/28/2017
QbD starts with an understanding of the quality target product profile. This allows potential critical quality attributes (CQAs) to be established and a risk assessment performed.
-
G-CON Gene Therapy Facility 2017
10/25/2017
PODs provide the environments for the entire upstream and downstream process for a state of the art gene therapy facility.
-
Turnkey Facility And Cleanroom Solutions Transform Biopharma Manufacturing
10/6/2017
Flexible and modular facility designs that can be built in a factory, shipped to the site and then rapidly assembled have been recognized and are being addressed by innovative suppliers.